IIM
Ipswich Investment Management Portfolio holdings
AUM
$414M
This Quarter Return
+7.82%
1 Year Return
+15.04%
3 Year Return
+70.41%
5 Year Return
+132.95%
10 Year Return
+315.52%
AUM
$296M
AUM Growth
+$296M
(+36%)
Cap. Flow
+$65.5M
Cap. Flow
% of AUM
22.15%
Top 10 Holdings %
Top 10 Hldgs %
28.52%
Holding
168
New
86
Increased
42
Reduced
34
Closed
1
Top Buys
| 1 |
Amazon
AMZN
|
$6.67M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$4.81M |
| 3 |
Estee Lauder
EL
|
$3.41M |
| 4 |
LLL
L3 Technologies, Inc.
LLL
|
$2.51M |
| 5 |
APA Corp
APA
|
$2.25M |
Top Sells
| 1 |
Labcorp
LH
|
$1.83M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$618K |
| 3 |
CRISPR Therapeutics
CRSP
|
$473K |
| 4 |
Cameco
CCJ
|
$379K |
| 5 |
Apple
AAPL
|
$339K |
Sector Composition
| 1 | Healthcare | 17.19% |
| 2 | Technology | 16.52% |
| 3 | Energy | 13.66% |
| 4 | Industrials | 12.26% |
| 5 | Financials | 10.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Estee Lauder
EL
$33B
| $3.41M | 1.15% |
+23,455
| New | +$3.41M |
|
27
Diageo
DEO
$62.1B
| $3.37M | 1.14% |
23,771
+300
| +1% | +$42.5K |
|
28
Accenture
ACN
$162B
| $3.25M | 1.1% |
19,110
+2,175
| +13% | +$370K |
|
29
Texas Instruments
TXN
$184B
| $3.24M | 1.1% |
30,215
+686
| +2% | +$73.6K |
|
30
AbbVie
ABBV
$372B
| $3.11M | 1.05% |
32,875
+2,920
| +10% | +$276K |
|
31
GSK
GSK
$79.9B
| $3.02M | 1.02% |
75,065
+5,880
| +8% | +$236K |
|
|
32
APA Corp
APA
$8.31B
| $2.81M | 0.95% |
59,025
+47,195
| +399% | +$2.25M |
|
33
Baxter International
BAX
$12.7B
| $2.8M | 0.95% |
36,375
-1,497
| -4% | -$115K |
|
34
Church & Dwight Co
CHD
$22.7B
| $2.72M | 0.92% |
45,809
-432
| -0.9% | -$25.7K |
|
35
Marsh & McLennan
MMC
$101B
| $2.66M | 0.9% |
32,190
+1,405
| +5% | +$116K |
|
36
Abbott
ABT
$231B
| $2.59M | 0.88% |
35,325
+3,200
| +10% | +$235K |
|
37
PepsiCo
PEP
$204B
| $2.52M | 0.85% |
22,496
+732
| +3% | +$81.8K |
|
|
LLL
38
DELISTED
L3 Technologies, Inc.
LLL
| $2.51M | 0.85% |
+11,817
| New | +$2.51M |
|
|
PX
39
DELISTED
Praxair Inc
PX
| $2.51M | 0.85% |
15,609
+316
| +2% | +$50.8K |
|
40
Scotiabank
BNS
$77.6B
| $2.41M | 0.82% |
40,481
+826
| +2% | +$49.3K |
|
41
Emerson Electric
EMR
$74.3B
| $2.37M | 0.8% |
30,960
+35
| +0.1% | +$2.68K |
|
42
DuPont de Nemours
DD
$32.2B
| $2.26M | 0.77% |
35,194
+1,538
| +5% | +$98.9K |
|
43
Regenxbio
RGNX
$451M
| $2.26M | 0.76% |
29,932
-1,339
| -4% | -$101K |
|
44
Duke Energy
DUK
$95.3B
| $2.25M | 0.76% |
28,154
-74
| -0.3% | -$5.92K |
|
45
Biogen
BIIB
$19.4B
| $2.24M | 0.76% |
+6,345
| New | +$2.24M |
|
46
Schlumberger
SLB
$55B
| $2.19M | 0.74% |
35,908
-3,478
| -9% | -$212K |
|
47
Novartis
NVS
$245B
| $2.17M | 0.73% |
25,185
-145
| -0.6% | -$12.5K |
|
48
IBM
IBM
$227B
| $2.12M | 0.72% |
14,028
+198
| +1% | +$29.9K |
|
|
49
CRISPR Therapeutics
CRSP
$4.71B
| $2.06M | 0.7% |
46,405
-10,675
| -19% | -$473K |
|
50
Truist Financial
TFC
$60.4B
| $2.02M | 0.68% |
41,640
-141
| -0.3% | -$6.84K |
|